Metraipolis › archive › dc_d65c29efd545

A randomized double-blind placebo-controlled phase I/II clinical trial of a human papillomavirus therapeutic vaccine, PepCan, for reducing head and neck… — Europe PMC PMID:42249801

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42249801
DOI
10.18632/oncotarget.28892
License (as archived)
solo-consultazione
Archived
2026-10-31T21:23:47.662Z
SHA-256 of the archived text
93045e558682f54213303e803e770dc5c39e7ed30b8eed0fb766f2c7e749dbc7
Stable URL of this page
https://metraipolis.com/documento/dc_d65c29efd545

How to cite

A randomized double-blind placebo-controlled phase I/II clinical trial of a human papillomavirus therapeutic vaccine, PepCan, for reducing head and neck… — Europe PMC PMID:42249801 — Europe PMC (en), https://europepmc.org/article/MED/42249801 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d65c29efd545 (Metraipolis archive dc_d65c29efd545, sha256 93045e558682f54213303e803e770dc5c39e7ed30b8eed0fb766f2c7e749dbc7)
BibTeX
@misc{dcd65c29efd545,
  title = {A randomized double-blind placebo-controlled phase I/II clinical trial of a human papillomavirus therapeutic vaccine, PepCan, for reducing head and neck… — Europe PMC PMID:42249801},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42249801},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d65c29efd545; sha256 93045e558682f54213303e803e770dc5c39e7ed30b8eed0fb766f2c7e749dbc7},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42249801. Agents can read the archived copy with the MCP tool read_document.